MUSC Hollings Cancer Center - Report to the Community 2026 - Flipbook - Page 5
Associate Directors
Matthew J. Carpenter, Ph.D.
A. Craig Lockhart, M.D., MHS, FASCO
Associate Director, Behavioral and Population Science
Associate Director, Clinical Science
Marvella E. Ford, Ph.D.
Associate Director, Community Outreach
and Engagement
Denis C. Guttridge, Ph.D.
Besim Ogretmen, Ph.D.
Associate Director, Basic Science
Nicholas Shungu, M.D.
Associate Director, Translational Science
Associate Director, Of昀椀ce of Workforce
Development and Organizational Culture
Amanda LaRue, Ph.D.
Benjamin Toll, Ph.D.
Associate Director, Shared Resources
Associate Director, Education and Training
Clinical Leadership
Jason Newman, M.D.
Chief, Oncology Integrated Center of Clinical Excellence
Kevin Becker, M.D.
Associate Chief, Oncology Integrated Center of
Clinical Excellence
Kristin Mensonides, MHA, MLS, FACHE
System Administrative Of昀椀cer, Oncology
Integrated Center of Clinical Excellence
David Marshall, M.D.
Medical Director, Clinical Trials Of昀椀ce
Chair, Radiation Medicine
Kevin Roggin, M.D., FACS, FSSO
Clinical Director, Surgical Oncology
Abi Sivapiragasam, M.D.
Director, Medical Oncology
Survivorship Leadership
Evan Graboyes, M.D., MPH
Director, Survivorship and Cancer Outcomes Research (SCOR)
Medical Director, Survivorship Program
Michelle Mollica, Ph.D., MPH, RN, OCN, FAAN
Director, Survivorship Care and Delivery
Report to the Community 2026 | 3